This invention discloses an active five-tone
speech therapy system, primarily targeting individuals with speech dysfunction after
stroke. Its core active five-tone
speech therapy has been proven in clinical trials to effectively improve spontaneous speech, auditory comprehension, repetition, and naming functions in patients with subacute and chronic aphasia following
stroke. Building upon this therapy, this invention adds a module for collecting and differentiating the patient's five internal organ syndrome elements, creating a novel, online, therapist-free
remote diagnosis and treatment
software that integrates "patient symptom and sign information collection – five internal organ syndrome element assessment – five-tone
repertoire recommendation – active five-tone
speech therapy – speech collection during training, accuracy and pronunciation standard assessment, training difficulty adjustment, scale evaluation, and training
efficacy feedback." This invention can improve the applicability of Western classical melodic intonation therapy to Chinese aphasia patients, mobilize patients' subjective initiative, provide precise five-tone music recommendations and
individualized treatment for patients with different syndrome types, enhance the
rehabilitation effect and efficiency of existing
speech training, reduce the
workload of therapists, alleviate the medical and economic burden on patients, and lay the foundation for the development of subsequent active five-tone speech therapy
remote diagnosis and treatment equipment.